Teprotumumab clinical trials

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

This study is testing a new medicine, teprotumumab, for people with active Thyroid Eye Disease (TED). We want to see if it can help reduce bulging eyes (proptosis) compared to a dummy medicine (placebo). It involves adults aged 18-80.